Hepatic induction potency of hypolipidaemic drugs in the rat following long-term administration: influence of different dosing regimens

References

• Arnold A., McAuliff J. P., Powers L. G., Phillips D. K., Beyler A. L. The results of animal studies with ciprofibrate, a new orally effective hypolipidaemic drug. Atherosclerosis 1979; 32: 155–163
   PubMed Web of Science ®Google Scholar
• Awasthi Y. C., Beutler E., Srivastava S. K. Purification and properties of human erythrocyte glutathione peroxidase. Journal of Biological Chemistry 1975; 250: 5144–5149
   PubMed Web of Science ®Google Scholar
• Awasthi Y. C., Singh S. V., Goel S. K., Reddy J. K. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator. Biochemical and Biophysical Research Communications 1984; 123: 1012–1018
   PubMed Web of Science ®Google Scholar
• Beaufay H., Bendall D. S., Baudhuin P., Wattiaux R., De Duve C. Tissue fractionation studies. Analysis of mitochondrial fraction from rat liver by density-gradient centrifugation. Biochemical Journal 1959; 73: 628–637
   PubMed Web of Science ®Google Scholar
• Bieber L. L., Abraham T., Helmrath T. A rapid spectrophotometric assay for carnitine palmitoyltransferase. Analytical Biochemistry 1972; 50: 509–518
   PubMed Web of Science ®Google Scholar
• Bock P. P., Kramar R., Pavelka M. A rapid and sensitive assay for carnitine acetyltransferase. Cell Biology Monographs 1980; 7: 44–74
   Google Scholar
• Bronfman M., Inestrosa N. S., Leighton F. Fatty acid oxidation by human liver peroxisomes. Biochemical and Biophysical Research Communications 1979; 88: 1030–1036
   PubMedGoogle Scholar
• Cayen M. N. Disposition, metabolism and pharmacokinetics of antihyperlipidaemic agents in laboratory animals and man. Pharmacology and Therapeutics 1985; 29: 157–204
   PubMed Web of Science ®Google Scholar
• Eason C. T., Powles P., Henry G., Bonner F. W. The influence of pharmacokinetic differences between bezafibrate and ciprofibrate on gastric toxicity in the rat. Human Toxicology 1988 a; 7: 377–378
   Google Scholar
• Eason C. T., Spencer A. J., Pattison H. A., Howells D. D., Bonner F. W. Gastric effects of phenoxyisobutyrate derivatives in animals studies. Human Toxicology 1988 b; 7: 398–399
   Google Scholar
• Eason C. T., Spencer A. J., Pattison H. A., Howells D. D., Henry D., Bonner F. W. Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse and marmoset. Toxicology and Applied Pharmacology 1988; 95: 328–338
   PubMed Web of Science ®Google Scholar
• Eason C. T., Powles P., Henry G., Spencer A. J., Pattison A., Bonner F. W. The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat. Xenobiotica 1989; 19: 913–925
   PubMed Web of Science ®Google Scholar
• Edelson J., Benziger D. P., Arnold A., Beyler A. L. Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidaemic agent. Atherosclerosis 1979; 33: 351–357
   PubMed Web of Science ®Google Scholar
• Goldenberg H., Huttinger M., Kampfer P., Kramar R., Pavelka M. Effect of clofibrate application on morphology and enzyme content of liver peroxisomes. Histochemistry 1976; 46: 189–196
   PubMedGoogle Scholar
• Kahonen M. T., Ylikahri R. H. Effect of clofibrate treatment on the activity of carnitine acetyltransferase in rat tissues. FEBS Letters 1974; 43: 297–299
   PubMedGoogle Scholar
• Lalwani N. D., Reddy M. K., Qureshi S. A., Reddy J. K. Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-acetic acid (Wy-14, 643) in the semipurified diet. Carcinogenesis 1981; 2: 645–650
   PubMed Web of Science ®Google Scholar
• Lazarow P. B. Compartmentation of β-oxidation of fatty acids in peroxisomes. Metabolic Compartmentation, H. Sies. Academic Press, New York 1982; 317–329
   Google Scholar
• Lee Y. P., Takemori A. E., Lardy H. Enhanced oxidation of α-glycerophosphate by mitochondria of thyroid hormone fed rats. Journal of Biological Chemistry 1959; 234: 3051–3054
   PubMed Web of Science ®Google Scholar
• Lee Y. P., Lardy H. A. Influence of thyroid hormones on L-α-glycerophosphate dehydrogenases and other dehydrogenases in various organs of the rat. Journal of Biological Chemistry 1965; 240: 1427–1436
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mann A. H., Price S. C., Mitchell F. E., Grasso P., Hinton R. H., Bridges J. W. Comparison of the short-term effects of di-(2-ethylhexyl)phthalate, di-(n-hexyl)phthalate and di(n-octyl)phthalate in rats. Toxicology and Applied Pharmacology 1985; 81: 371–392
   PubMedGoogle Scholar
• Mitchell F. E., Price S. C., Hinton R. H., Grasso P., Bridges J. W. Time and dose-response study of the effects on rats of the plasticiser di-(2-ethylhexyl)phthalate. Toxicology and Applied Pharmacology 1985; 81: 371–392
   PubMed Web of Science ®Google Scholar
• Prospero T. D. Determination of mitochondrial enzymes in tissue homogenates. Method Developments in Biochemistry 1974; 4: 411–412
   Google Scholar
• Reddy J. K., Krishnakantha T. P. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 1975; 190: 787–789
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980; 283: 397–398
   PubMed Web of Science ®Google Scholar
• Sharma R., Lake B. G., Foster J., Gibson G. G. Microsomal cytochrome P-452 induction and peroxisomal proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship. Biochemical Pharmacology 1988; 37: 1193–1201
   PubMed Web of Science ®Google Scholar
• Sharma R., Lake B. G., Gibson G. G. Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies. Biochemical Pharmacology 1988 b; 37: 1203–1206
   PubMed Web of Science ®Google Scholar
• Spencer A. J., Barbolt T. A., Henry D. C., Eason C. T., Saufrschell R. J., Bonner F. W. Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidaemic agent, ciprofibrate. Toxicologic Pathology 1989; 17: 7–15
   PubMedGoogle Scholar